AffiliationCancer Research Campaign Gene Therapy Group, Paterson Institute for Cancer Research, Manchester, UK.
MetadataShow full item record
AbstractGene therapy has thus far promised much and delivered little. Much of this has been due to deficiencies in the reagents and methodologies employed in early clinical trials. Recent technological advances in vectors and haemopoietic stem cell manipulation, coupled with improved pre-clinical assays of gene transfer and expression in re-populating stem cells give cause for greater optimism. Here we review these advances and indicate areas requiring further development before clinical gene therapy in the haemopoietic system becomes a widely applicable treatment modality.
CitationProspects for gene therapy using haemopoietic stem cells. 2001, 14 (4):823-34 Best Pract Res Clin Haematol
JournalBest Practice & Research. Clinical Haematology
- [Development of gene therapy for hematopoietic stem cell using viral vectors].
- Authors: Dong WJ, Zu ZX, Liu DP, Liang CC
- Issue date: 2003 Apr
- Optimization of adenovirus serotype 35 vectors for efficient transduction in human hematopoietic progenitors: comparison of promoter activities.
- Authors: Sakurai F, Kawabata K, Yamaguchi T, Hayakawa T, Mizuguchi H
- Issue date: 2005 Oct
- Marker gene transfer into human haemopoietic cells using a herpesvirus saimiri-based vector.
- Authors: Doody GM, Leek JP, Bali AK, Ensser A, Markham AF, de Wynter EA
- Issue date: 2005 Feb
- Recombinant Sendai virus provides a highly efficient gene transfer into human cord blood-derived hematopoietic stem cells.
- Authors: Jin CH, Kusuhara K, Yonemitsu Y, Nomura A, Okano S, Takeshita H, Hasegawa M, Sueishi K, Hara T
- Issue date: 2003 Feb
- Hematopoietic stem cell gene therapy: progress toward therapeutic targets.
- Authors: Vollweiler JL, Zielske SP, Reese JS, Gerson SL
- Issue date: 2003 Jul